首页> 外文期刊>Asian Pacific Journal of Cancer Prevention >Association of Interleukin-27 rs 153109 Single Nucleotide Polymorphism with Spontaneous Resolution of Hepatitis C Virus - Genotype 4a Infection in Egyptian Patients
【24h】

Association of Interleukin-27 rs 153109 Single Nucleotide Polymorphism with Spontaneous Resolution of Hepatitis C Virus - Genotype 4a Infection in Egyptian Patients

机译:白细胞介素-27 rs 153109单核苷酸多态性与丙型肝炎病毒自发分辨率的单核苷酸多态性 - 基因型4a感染埃及患者

获取原文
           

摘要

Background: HCV is a major global health problem. IL-27 is a member of the IL-6/IL-12 cytokine family with a broad range of anti-inflammatory properties. Recent studies highlighted the effect of a SNP in the IL-27 promoter region on modulating the progression of infectious diseases and individual responses to therapy. Aim of the work: The present study investigated the potential role of (-964 A/G) SNP in the promoter region of IL-27p28 gene (alleles rs153109) on the outcome of HCV infection among genotype 4a infected patients. Materials and Methods: HCV genotyping confirmed that all of the HCV-infected patients had genotype 4a infection. Genomic DNA was extracted from 111 patients with chronic HCV infection, 42 spontaneous resolvers (SR) and 16 healthy controls. IL- 27p28.rs153109 genotyping was assessed using PCR-RFLP then confirmed by DNA sequencing. Results: The frequency of IL-27-p28.rs153109AA, AG, and GG genotypes among chronically infected subjects were 74.8 %, 25.2%, and 0% while among the SR, they were 57.1%, 35.7%, and 7.14%, respectively. Our data show the unique presence of G/G genotype in the SR group (3 patients; 7.14%). Moreover, the "G" allele frequencies among chronic and resolved subjects were 12.6% and 25.0%, respectively (p=0.0136). Importantly, subjects with the GG genotype were more likely to clear their HCV infection than those with the AA genotype (p=0.0118). Conclusions: HCV genotype 4a subjects with the IL-27-p28.rs153109 A/G and G/G genotype were more likely to clear their HCV infection. Therefore, we propose IL- 27p28.rs153109SNPas a genetic biomarker for predicting HCV infection outcome.
机译:背景:HCV是一个主要的全球健康问题。 IL-27是IL-6 / IL-12细胞因子家族的成员,具有广泛的抗炎特性。最近的研究强调了SNP在IL-27启动子区的影响调节传染病进展和对治疗的个体反应。作品的目的:本研究研究了IL-27P28基因启动子区(A964 A / G)SNP在IL-27P28基因(等位基因RS153109)的潜在作用对基因型4A感染患者的HCV感染结果。材料和方法:HCV基因分型证实,所有HCV感染患者都有基因型4A感染。从111例慢性HCV感染患者提取基因组DNA,42例自发腐蚀剂(SR)和16例健康对照。使用PCR-RFLP评估基因分型,然后通过DNA测序证实。结果:在慢性感染受试者中IL-27-P28.RS153109AA,AG和GG基因型的频率为74.8%,25.2%和0%,分别为57.1%,35.7%和7.14% 。我们的数据显示了SR组中G / G基因型的独特存在(3例患者; 7.14%)。此外,慢性和分辨受试者中的“G”等位基因频率分别为12.6%和25.0%(P = 0.0136)。重要的是,具有GG基因型的受试者更可能清除它们的HCV感染,而不是AA基因型的HCV感染(P = 0.0118)。结论:HCV基因型4A受试者的IL-27-P28.RS153109 A / g和G / g基因型更可能清除其HCV感染。因此,我们提出IL-27P28.RS153109SNPA遗传生物标志物,用于预测HCV感染结果。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号